Review



rtl plus buffer  (Qiagen)


Bioz Verified Symbol Qiagen is a verified supplier
Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Qiagen rtl plus buffer
    Rtl Plus Buffer, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 5328 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/RNeasy+Plus+Mini+Kit/pm41922576-99-7-10
    Average 99 stars, based on 5328 article reviews
    rtl plus buffer - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    RNA Sequencing:

    Article Title: PLK1 inhibition by onvansertib enhances paclitaxel efficacy and overcomes resistance in HR+/HER2- breast cancer refractory to endocrine therapy and CDK4/6 inhibitors
    Article Snippet: Images were captured using an inverted fluorescence microscope (Olympus). .. 168 RNA-Sequencing 169 Cells were treated with onvansertib (25 nM), paclitaxel (5 nM), or their combination for 48 170 h. Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen, Cat No. 74136) and samples 171 with RNA integrity number (RIN) ≥8 were used for poly(A)+ mRNA library preparation. ..

    Isolation:

    Article Title: PLK1 inhibition by onvansertib enhances paclitaxel efficacy and overcomes resistance in HR+/HER2- breast cancer refractory to endocrine therapy and CDK4/6 inhibitors
    Article Snippet: Images were captured using an inverted fluorescence microscope (Olympus). .. 168 RNA-Sequencing 169 Cells were treated with onvansertib (25 nM), paclitaxel (5 nM), or their combination for 48 170 h. Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen, Cat No. 74136) and samples 171 with RNA integrity number (RIN) ≥8 were used for poly(A)+ mRNA library preparation. ..

    Lysis:

    Article Title: Validated LC-MS/MS quantification of kynurenine pathway metabolites and pathway-balance ratios in brain tissue and microglial culture supernatant: application to neonatal stroke
    Article Snippet: .. In brief, total RNA was extracted using the Qiagen kit (Qiagen, Hilden, Germany; Cat# 74136) in 350 μL of RLT lysis buffer (Qiagen, Cat# 74136), which was split across three replicate wells and stored at −80 °C until RNA was extracted. .. RNA had an A260/280 ratio of 1.8–2.1 and an A260/230 ratio >1.8, as determined with a NanoDrop One Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific; RRID:SCR_023005).

    other:

    Article Title: Impairing Golgin-45 transcription factor activity unleashes malignant secretion in lung cancer
    Article Snippet: We purchased FBS, RPMI-1640, DMEM, PBS, Alexa Fluor–tagged secondary antibodies, paraformaldehyde, BSA, DAPI, ProLong Diamond Antifade Mountant, Triton X-100 from Thermo Fisher Scientific; puromycin from InvivoGene; Transwells and Matrigel-coated Boyden chambers from BD Biosciences; trypsin and Penicillin-Streptomycin solution from Corning; qScript cDNA super-Mix from Vazyme; SYBR Green Real-Time PCR Master Mixes from Bimake and Vazyme; HiFi DNA Assembly Master Mix (Gibson) (E2621) from NEB; protease/phosphatase inhibitor cocktail from Cell Signaling Technology; CCK-8 (K1018) from APExBIO; 10× RIPA cell lysis buffer (20-188), miRNA-34a, miRNA-15a, miRNA-16 mimics and Zip-34a, 5-Azacytidine (A2385), Brefeldin A (B7651) , Bafilomycin A1 (BafA1) (B1793), 1,6Hexanedio solution (88571), MG-132 (M7449) and Cycloheximide (CHX) (C7698) from MilliporeSigma; RNeasy Plus Mini Kit (74136) from QIAGEN; human recombinant JUN protein (LS-G26607-50), human recombinant FOSL1 protein (LS-G15972) from LifeSpan BioSciences; siRNAs against human TET1 (SASI_Hs01_00168428), TET2 (SASI_Hs02_00350302), TET3 (SASI_Hs02_00364816), GORASP2 (SASI_Hs02_00348040, SASI_Hs01_00012371), SPP1 (SASI_Hs01_00117408, SASI_Hs01_00117411), NTSR1 (SASI_Hs01_00155439), CNTN1 (SASI_Hs02_00332652), KCTD12 (SASI_Hs01_00206464), KLF13 (SASI_Hs01_00137161), LSR (SASI_Hs01_00089139), CPEB2 (SASI_Hs01_00048530), JUP (SASI_Hs01_00246520), FOSL1 (SASI_Hs01_00191186, SASI_Hs02_00339593) from MilliporeSigma; We purchased primary antibodies against G45 (OAAN01805) from Aviva Systems Biology; against G55 from Novus Biologicals (NB100-74431) or from Proteintech (10598-1-AP) ; against GM130 (560066) from BD Transduction Laboratories; against α-tubulin (T9026) from MilliporeSigma; against CREB (9197), HA-Tag (3724), COILIN (14168), SC-35/SRRM2 (19700), Myc-Tag (2272), H3 (4620), ubiquitin (43124), Acetyl-Histone H3 (Lys27) (8173), Tri-Methyl-Histone H3 (Lys9) (13969), HDAC1 (5356), HDAC2 (5113) from Cell Signaling Technology; against ACBD3 (sc-101277) , GFP (sc-9996), GRASP65 (sc-374423), from Santa Cruz Biotechnology; against SPP1 (229521-AP), IGFBP2 (11065-3-AP), PML (21041-1-AP) and tubulin (80762-1-RR) from Proteintech; lentiCRISPR v2 (52961), lentiCRISPR v2-Blast (83480), Flag-TurboID(124646), OPN(-1206)-luc (31106), pCMV-GST-IRP1(216827) from Addgene.

    Article Title: Pectin alleviates alcohol-associated liver disease partly through cell-type-specific aryl hydrocarbon receptor signaling in female mice.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, peptides, and recombinant proteins Absolute ethanol Fisher Cat# 16606002 Pectin Sigma-Aldrich Cat# 93854 QIAzol lysis reagent Qiagen Cat# 79306 β-Mercaptoethanol Sigma-Aldrich Cat# M6250 Dithiothreitol Life technologies Cat# 707265ML dNTP mix Thermoscientific Cat# R0191 Oligo(dT) primer Merck Cat# 10814270001 M-MuLV reverse transcriptase Invitrogen Cat# 10338842 RNase inhibitor Merck Cat# 3335402001 SYBR Green master mix Roche Diagnostics Cat# 4887352001 Hoechst 33342 Molecular Probes/Life Technologies Cat# H-3570 Propidium iodide Thermo Fisher Scientific Cat# P3566 Fixable Viability Dye eFluor 506 Thermo Fisher Scientific Cat# 65–0866–18 Fixable Viability Dye eFluor 780 Thermo Fisher Scientific Cat# 65–0865–18 cOmplete Mini EDTA-free Protease Inhibitor Cocktail Roche Cat# 11836170001 PhosSTOP phosphatase inhibitor cocktail Merck Cat# 4906845001 Prestained Protein Ladder Plus Euromedex Cat# 06P-0211 PVDF membrane Millipore Cat# IPVH00010 Immobilon Western chemiluminescent HRP substrate Millipore Cat# WBKL50500 Sucrose Sigma-Aldrich Cat# S8501 OCT compound Sakura Finetek France SAS Cat# 4583 Triton X-100 Sigma-Aldrich Cat# T8787 BSA, IgG-free and protease-free Jackson ImmunoResearch Cat# 001–000–162 Donkey serum Jackson ImmunoResearch Cat# 017–000–121 Goat serum Jackson ImmunoResearch Cat# 005–000–121 DAPI Thermo Fisher Scientific Cat# D1306 Phalloidin Thermo Fisher Scientific Cat# A22287 Aqua-Poly/Mount Polysciences Cat# 18606–5 Critical commercial assays QIAamp Fast DNA Stool Mini Kit Qiagen Cat# 51604 RNeasy Lipid Tissue Mini Kit Qiagen Cat# 74804 RNeasy Plus Mini Kit Qiagen Cat# 74136 RNA 6000 Nano Kit Agilent Cat# 5067–1511 Custom U-PLEX Biomarker Group 1 (mouse) multiplex assay for IL-6, IL-10, and IL-22 Meso Scale Discovery Cat# K15069M-1 Lamina Propria Dissociation Kit, mouse Miltenyi Biotec Cat# 130–097–410 BD fixation/permeabilization reagents BD Biosciences Cat# 554722 Pierce BCA Protein Assay Kit Thermo Scientific Cat# 23225 Triglyceride Quantification Assay Kit Abcam Cat# ab65336 Oligonucleotides PCR1F_460 primer Eurogentec 5′-CTTTCCCTACACGACGCTCTT CCGATCTACGGRAGGCAGCAG-3′ PCR1R_460 primer Eurogentec 5′-GGAGTTCAGACGTGTGCTCTTCC GATCTTACCAGGGTATCTAATCCT-3′ Ahrflox genotyping primer oIMR6075 Eurogentec 5′-CAGTGGGAATAAGGCAAGAGTGA-3′ (Continued on next page) Cell Reports 45, 118085, October 27, 2026 15

    RNA Extraction:

    Article Title: Leveraging high-throughput proteomics and AI-based protein folding to accelerate VAV1 molecular glue discovery.
    Article Snippet: .. RNA extraction, Reverse Transcription qPCR RNA for qPCR was extracted from cells using the RNeasy Plus Mini Kit (Qiagen, 74136) according to the manufacturer’s protocol. .. For quantification of VAV1 mRNA levels after treatment, expression of target genes was quantified using FlysisAmp Cells-to-CT 1-Step SYBR Green Kit (Vazyme, CL132-01).

    Reverse Transcription:

    Article Title: Leveraging high-throughput proteomics and AI-based protein folding to accelerate VAV1 molecular glue discovery.
    Article Snippet: .. RNA extraction, Reverse Transcription qPCR RNA for qPCR was extracted from cells using the RNeasy Plus Mini Kit (Qiagen, 74136) according to the manufacturer’s protocol. .. For quantification of VAV1 mRNA levels after treatment, expression of target genes was quantified using FlysisAmp Cells-to-CT 1-Step SYBR Green Kit (Vazyme, CL132-01).

    Real-time Polymerase Chain Reaction:

    Article Title: Leveraging high-throughput proteomics and AI-based protein folding to accelerate VAV1 molecular glue discovery.
    Article Snippet: .. RNA extraction, Reverse Transcription qPCR RNA for qPCR was extracted from cells using the RNeasy Plus Mini Kit (Qiagen, 74136) according to the manufacturer’s protocol. .. For quantification of VAV1 mRNA levels after treatment, expression of target genes was quantified using FlysisAmp Cells-to-CT 1-Step SYBR Green Kit (Vazyme, CL132-01).



    Similar Products

    86
    Cadence Design Systems encounter rtl compiler
    Encounter Rtl Compiler, supplied by Cadence Design Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/compiler+encounter+rtl/us12657645-1454-23-27
    Average 86 stars, based on 1 article reviews
    encounter rtl compiler - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    99
    Qiagen rtl plus buffer
    Rtl Plus Buffer, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/RNeasy+Plus+Mini+Kit/pm41922576-99-7-10
    Average 99 stars, based on 1 article reviews
    rtl plus buffer - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Qiagen rtl buffer
    Rtl Buffer, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/RNeasy+Micro+Kit/bio_rxiv__64898__2026__03__24__714045-184-21-23
    Average 99 stars, based on 1 article reviews
    rtl buffer - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    86
    10X Genomics 10x visium rtl probe capture barcodes
    a , The C-G2P framework. Mice are HDTV injected with a pool of barcoded perturbation plasmids leading to sleeping beauty (SB)-transposon-mediated stable integration into the genome of hepatocytes. Higher-order combinatorial perturbations drive mosaic liver tumour development in a conceptual 2 n combination space for clonal selection (RUBIX). Direct barcode identification is achieved by linking perturbations to 50-nt barcode sequences that are captured and identified by RTL probes as embedded in the <t>10X</t> Visium for FFPE platform (PERTURB-CAST). Endogenous transcripts are captured alongside barcodes, hence enabling simultaneous mapping of genotypes (as defined by the presence of perturbations) and phenotypes (as defined by transcriptional signatures) on the same tissue section. b , PERTURB-CAST barcode selection. Transcripts not expressed in murine liver are identified using public databases. Their respective <t>50-nt</t> <t>RTL-probe</t> capture sequences are used as barcodes detected by redeployed commercially available RTL probes provided with the 10X Visium for FFPE mouse kit . Barcodes derived from chemosensory receptor transcripts are embedded in perturbation plasmids as triplet arrays.
    10x Visium Rtl Probe Capture Barcodes, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/10x+barcodes+capture+probe+rtl+visium/pmc12823398-323-23-35
    Average 86 stars, based on 1 article reviews
    10x visium rtl probe capture barcodes - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    97
    Qiagen rtl buffer ceramic beads
    a , The C-G2P framework. Mice are HDTV injected with a pool of barcoded perturbation plasmids leading to sleeping beauty (SB)-transposon-mediated stable integration into the genome of hepatocytes. Higher-order combinatorial perturbations drive mosaic liver tumour development in a conceptual 2 n combination space for clonal selection (RUBIX). Direct barcode identification is achieved by linking perturbations to 50-nt barcode sequences that are captured and identified by RTL probes as embedded in the <t>10X</t> Visium for FFPE platform (PERTURB-CAST). Endogenous transcripts are captured alongside barcodes, hence enabling simultaneous mapping of genotypes (as defined by the presence of perturbations) and phenotypes (as defined by transcriptional signatures) on the same tissue section. b , PERTURB-CAST barcode selection. Transcripts not expressed in murine liver are identified using public databases. Their respective <t>50-nt</t> <t>RTL-probe</t> capture sequences are used as barcodes detected by redeployed commercially available RTL probes provided with the 10X Visium for FFPE mouse kit . Barcodes derived from chemosensory receptor transcripts are embedded in perturbation plasmids as triplet arrays.
    Rtl Buffer Ceramic Beads, supplied by Qiagen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/Ceramic+Beads/pmc12289986__41541_2025_1232_MOESM1_ESM-11-25-56
    Average 97 stars, based on 1 article reviews
    rtl buffer ceramic beads - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    86
    Magen Biotechnology Co Ltd rtl lysis buffer
    a , The C-G2P framework. Mice are HDTV injected with a pool of barcoded perturbation plasmids leading to sleeping beauty (SB)-transposon-mediated stable integration into the genome of hepatocytes. Higher-order combinatorial perturbations drive mosaic liver tumour development in a conceptual 2 n combination space for clonal selection (RUBIX). Direct barcode identification is achieved by linking perturbations to 50-nt barcode sequences that are captured and identified by RTL probes as embedded in the <t>10X</t> Visium for FFPE platform (PERTURB-CAST). Endogenous transcripts are captured alongside barcodes, hence enabling simultaneous mapping of genotypes (as defined by the presence of perturbations) and phenotypes (as defined by transcriptional signatures) on the same tissue section. b , PERTURB-CAST barcode selection. Transcripts not expressed in murine liver are identified using public databases. Their respective <t>50-nt</t> <t>RTL-probe</t> capture sequences are used as barcodes detected by redeployed commercially available RTL probes provided with the 10X Visium for FFPE mouse kit . Barcodes derived from chemosensory receptor transcripts are embedded in perturbation plasmids as triplet arrays.
    Rtl Lysis Buffer, supplied by Magen Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rtl/buffer+lysis+rl/pm40650228-207-8-11
    Average 86 stars, based on 1 article reviews
    rtl lysis buffer - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    a , The C-G2P framework. Mice are HDTV injected with a pool of barcoded perturbation plasmids leading to sleeping beauty (SB)-transposon-mediated stable integration into the genome of hepatocytes. Higher-order combinatorial perturbations drive mosaic liver tumour development in a conceptual 2 n combination space for clonal selection (RUBIX). Direct barcode identification is achieved by linking perturbations to 50-nt barcode sequences that are captured and identified by RTL probes as embedded in the 10X Visium for FFPE platform (PERTURB-CAST). Endogenous transcripts are captured alongside barcodes, hence enabling simultaneous mapping of genotypes (as defined by the presence of perturbations) and phenotypes (as defined by transcriptional signatures) on the same tissue section. b , PERTURB-CAST barcode selection. Transcripts not expressed in murine liver are identified using public databases. Their respective 50-nt RTL-probe capture sequences are used as barcodes detected by redeployed commercially available RTL probes provided with the 10X Visium for FFPE mouse kit . Barcodes derived from chemosensory receptor transcripts are embedded in perturbation plasmids as triplet arrays.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , The C-G2P framework. Mice are HDTV injected with a pool of barcoded perturbation plasmids leading to sleeping beauty (SB)-transposon-mediated stable integration into the genome of hepatocytes. Higher-order combinatorial perturbations drive mosaic liver tumour development in a conceptual 2 n combination space for clonal selection (RUBIX). Direct barcode identification is achieved by linking perturbations to 50-nt barcode sequences that are captured and identified by RTL probes as embedded in the 10X Visium for FFPE platform (PERTURB-CAST). Endogenous transcripts are captured alongside barcodes, hence enabling simultaneous mapping of genotypes (as defined by the presence of perturbations) and phenotypes (as defined by transcriptional signatures) on the same tissue section. b , PERTURB-CAST barcode selection. Transcripts not expressed in murine liver are identified using public databases. Their respective 50-nt RTL-probe capture sequences are used as barcodes detected by redeployed commercially available RTL probes provided with the 10X Visium for FFPE mouse kit . Barcodes derived from chemosensory receptor transcripts are embedded in perturbation plasmids as triplet arrays.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Injection, Selection, Derivative Assay

    a , Frequency of liver tumour samples with at least k potential driver mutations per sample in The Cancer Genome Atlas Program (TCGA) HCC dataset. Potential drivers were defined as either amplification or fusion of known COSMIC oncogenes, or homozygous deletion, nonsense mutation, splice site mutation or frameshift deletion/insertion in tumour-suppressor genes. b , Frequent alterations observed in human liver cancer (The Cancer Genome Atlas Program HCC dataset) are ‘geno-copied’ in a C-G2P mouse model (oncoprint based on https://www.cbioportal.org/study/summary?id=lihc_tcga ). ORF, open reading frame; RNAi, RNA interference. c , RUBIX mouse model generated in this study. Schematic overview of sleeping beauty transposon perturbation plasmids to ectopically overexpress genes of interest (oncogenic-driver perturbations) or shRNA to enable gene knockdown (tumour-suppressor perturbations). Functional elements are highlighted. BC, barcode in which three redeployed RTL-probe capture sequences (as indicated) are embedded; EF1, polymerase II promoter; IR, inverted/direct repeats of sleeping beauty transposon; pA: polyadenylation signal; sh, shRNA embedded in miRE context. Note that we used Visium mouse transcriptome probe set v1 to derive barcodes. Each 50-nt barcode is separated and flanked by spacer sequences of approximately 20 nt to avoid potential steric hindrance during hybridization. Further information in .

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Frequency of liver tumour samples with at least k potential driver mutations per sample in The Cancer Genome Atlas Program (TCGA) HCC dataset. Potential drivers were defined as either amplification or fusion of known COSMIC oncogenes, or homozygous deletion, nonsense mutation, splice site mutation or frameshift deletion/insertion in tumour-suppressor genes. b , Frequent alterations observed in human liver cancer (The Cancer Genome Atlas Program HCC dataset) are ‘geno-copied’ in a C-G2P mouse model (oncoprint based on https://www.cbioportal.org/study/summary?id=lihc_tcga ). ORF, open reading frame; RNAi, RNA interference. c , RUBIX mouse model generated in this study. Schematic overview of sleeping beauty transposon perturbation plasmids to ectopically overexpress genes of interest (oncogenic-driver perturbations) or shRNA to enable gene knockdown (tumour-suppressor perturbations). Functional elements are highlighted. BC, barcode in which three redeployed RTL-probe capture sequences (as indicated) are embedded; EF1, polymerase II promoter; IR, inverted/direct repeats of sleeping beauty transposon; pA: polyadenylation signal; sh, shRNA embedded in miRE context. Note that we used Visium mouse transcriptome probe set v1 to derive barcodes. Each 50-nt barcode is separated and flanked by spacer sequences of approximately 20 nt to avoid potential steric hindrance during hybridization. Further information in .

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Amplification, Mutagenesis, Generated, shRNA, Knockdown, Functional Assay, Hybridization

    Schematic overview of Sleeping Beauty transposon perturbation plasmids to ectopically overexpress genes-of-interest (oncogenic-driver perturbations) or shRNA to enable gene knockdown (tumor-suppressor perturbations). Functional elements are highlighted. IR: Inverted/direct repeats of sleeping beauty transposon; GFP: green fluorescent protein, mK2: mKate2 red fluorescent protein, EF1: Polymerase II promoter; U6: Polymerase III promoter; pA: polyadenylation signal; sh: short hairpin RNA embedded in mir-E context; BC: a barcode in which 3 redeployed RTL-probe capture sequences (as indicated) are embedded. Note that we used Visium Mouse Transcriptome Probe Set v1 to derive barcodes. Each 50 nt barcode is separated and flanked by ca. 20 nt spacer sequences to avoid potential steric hindrance during hybridization. Spacer sequences used were derived from T7 and T3 promoters and/or AsCas12a-DR sequences and/or 10X Capture sequences cs1 and cs2 (not shown). Functionality of spacer sequences was not tested in this study. Note that plasmids were equipped with multiple orthogonal barcodes at varying positions. See Methods for further information.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: Schematic overview of Sleeping Beauty transposon perturbation plasmids to ectopically overexpress genes-of-interest (oncogenic-driver perturbations) or shRNA to enable gene knockdown (tumor-suppressor perturbations). Functional elements are highlighted. IR: Inverted/direct repeats of sleeping beauty transposon; GFP: green fluorescent protein, mK2: mKate2 red fluorescent protein, EF1: Polymerase II promoter; U6: Polymerase III promoter; pA: polyadenylation signal; sh: short hairpin RNA embedded in mir-E context; BC: a barcode in which 3 redeployed RTL-probe capture sequences (as indicated) are embedded. Note that we used Visium Mouse Transcriptome Probe Set v1 to derive barcodes. Each 50 nt barcode is separated and flanked by ca. 20 nt spacer sequences to avoid potential steric hindrance during hybridization. Spacer sequences used were derived from T7 and T3 promoters and/or AsCas12a-DR sequences and/or 10X Capture sequences cs1 and cs2 (not shown). Functionality of spacer sequences was not tested in this study. Note that plasmids were equipped with multiple orthogonal barcodes at varying positions. See Methods for further information.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: shRNA, Knockdown, Functional Assay, Hybridization, Derivative Assay

    a , RUBIX with a pool-of-8 plasmid mix results in rapid liver tumour development. Injection of a shRNA targeting Renilla (shRen; matching total plasmid concentration for pool-of-8 mix) served as control, n = 2 each group. Representative H&E-stained samples revealing multiple tumour nodules from the two individual animals are shown. Absence of tumours in the control group (shRen only) indicates that random integration of transposon plasmids itself is unlikely to contribute to tumorigenesis. b , Tissue preprocessing. Following liver tumour development, livers were extracted, divided and processed to FFPE as well as fresh frozen specimens. FFPE samples were initially sectioned to enable sample selection. c , C-G2P liver samples. Overview of three representative FFPE samples used in this study. A total of 513 tumour nodules (red outline) were identified based on histopathological examination (based on H&E). d , Overview of ROIs selected for 10X Visium. 6 segregated regions were selected across 3 FFPE samples. Squares indicate approximate position of ROIs selected for ST. Orange: first 10X Visium run, light orange: first 10X Visium run, replicate ROI; blue: second 10X Visium run; black: 10X Visium CytAssist run. Note overlap between ROIs, where serial sections are used for 10X Visium. e , 10X Visium workflow. Samples for ST are derived directly from FFPE blocks and mounted on 10X Visium slides. f , 10X Visium CytAssist workflow. Samples for ST are derived from sections already mounted on glass slides and transferred to 10X Visium slides using the 10X CytAssist instrument. g , Overview of all samples used for ST. 12 samples from a single RUBIX experiment with two animals were used for 10X Visium in this study. Respective H&E stainings are depicted. Note that the utility of sample ML-II_B_2Cyt is constrained by tissue detachment of the sample during the processing for 10X Visium CytAssist and was not included for further analyses (asterisk). QC summary stats for each sample related to Visium runs performed are provided.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , RUBIX with a pool-of-8 plasmid mix results in rapid liver tumour development. Injection of a shRNA targeting Renilla (shRen; matching total plasmid concentration for pool-of-8 mix) served as control, n = 2 each group. Representative H&E-stained samples revealing multiple tumour nodules from the two individual animals are shown. Absence of tumours in the control group (shRen only) indicates that random integration of transposon plasmids itself is unlikely to contribute to tumorigenesis. b , Tissue preprocessing. Following liver tumour development, livers were extracted, divided and processed to FFPE as well as fresh frozen specimens. FFPE samples were initially sectioned to enable sample selection. c , C-G2P liver samples. Overview of three representative FFPE samples used in this study. A total of 513 tumour nodules (red outline) were identified based on histopathological examination (based on H&E). d , Overview of ROIs selected for 10X Visium. 6 segregated regions were selected across 3 FFPE samples. Squares indicate approximate position of ROIs selected for ST. Orange: first 10X Visium run, light orange: first 10X Visium run, replicate ROI; blue: second 10X Visium run; black: 10X Visium CytAssist run. Note overlap between ROIs, where serial sections are used for 10X Visium. e , 10X Visium workflow. Samples for ST are derived directly from FFPE blocks and mounted on 10X Visium slides. f , 10X Visium CytAssist workflow. Samples for ST are derived from sections already mounted on glass slides and transferred to 10X Visium slides using the 10X CytAssist instrument. g , Overview of all samples used for ST. 12 samples from a single RUBIX experiment with two animals were used for 10X Visium in this study. Respective H&E stainings are depicted. Note that the utility of sample ML-II_B_2Cyt is constrained by tissue detachment of the sample during the processing for 10X Visium CytAssist and was not included for further analyses (asterisk). QC summary stats for each sample related to Visium runs performed are provided.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Plasmid Preparation, Injection, shRNA, Concentration Assay, Control, Staining, Selection, Derivative Assay

    a , RUBIX establishes hundreds of coexisting tumours in the context of native tissue. Respective H&E-stained tissue samples for six topographically separated regions (approximately 6 × 6 mm) that were used for 10X Visium for FFPE-spatial transcriptomics analysis. A total of 324 nodules (colour-coded and numbered) were annotated. Colours were chosen arbitrarily. b , PERTUB-CAST allows perturbation-specific barcode identification. Average log(1 p )-transformed expression of all 38 barcode-associated transcripts used (left). Combined data for the reference control liver datasets from ref. and the six main spatial transcriptomics samples (C-G2P). Spatially resolved expression of triplet barcodes (as indicated in Fig. ) for each of the eight perturbations (top right). Aggregated log(1 p )-transformed and quantile-rescaled expression per 10X Visium spot. A representative sample is shown. Average log(1 p )-transformed expression of individual barcodes in each triplet array for each perturbation averaged across the six spatial transcriptomics samples (bottom right). c , Conversion of PERTURB-CAST barcode signals to perturbation maps. Spatially resolved visualization of the inferred probabilities indicating the presence or absence of each of the eight perturbations associated with annotated tumour nodules . A representative sample is displayed. b , c , Both the quantitative barcode expression ( b ) and probabilities ( c ) of all samples can be explored through the interactive web browser https://chocolat-g2p.dkfz.de/ . d , Validation of inferred perturbation integration. A GLM model predicts the phenotype expression signals based on the estimated probabilities of perturbation presence using Bayesian modelling . Phenotypes are defined as direct target transcripts associated with perturbations such as shPten– Pten and NICD– Notch1 . Expression data were log(1 p )-transformed. GS, a well-established marker for active WNT signalling in murine livers, was used to infer mtCtnnb1-GS-positive phenotype via IHC on a corresponding serial section. Baseline depicts background phenotype marker expression. Data are presented as feature coefficients shown as mean and error bars depict 3σ confidence intervals (CIs). Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Mapping GS IHC data are derived from three corresponding sections from a single RUBIX experiment with two animals. A representative sample section is displayed.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , RUBIX establishes hundreds of coexisting tumours in the context of native tissue. Respective H&E-stained tissue samples for six topographically separated regions (approximately 6 × 6 mm) that were used for 10X Visium for FFPE-spatial transcriptomics analysis. A total of 324 nodules (colour-coded and numbered) were annotated. Colours were chosen arbitrarily. b , PERTUB-CAST allows perturbation-specific barcode identification. Average log(1 p )-transformed expression of all 38 barcode-associated transcripts used (left). Combined data for the reference control liver datasets from ref. and the six main spatial transcriptomics samples (C-G2P). Spatially resolved expression of triplet barcodes (as indicated in Fig. ) for each of the eight perturbations (top right). Aggregated log(1 p )-transformed and quantile-rescaled expression per 10X Visium spot. A representative sample is shown. Average log(1 p )-transformed expression of individual barcodes in each triplet array for each perturbation averaged across the six spatial transcriptomics samples (bottom right). c , Conversion of PERTURB-CAST barcode signals to perturbation maps. Spatially resolved visualization of the inferred probabilities indicating the presence or absence of each of the eight perturbations associated with annotated tumour nodules . A representative sample is displayed. b , c , Both the quantitative barcode expression ( b ) and probabilities ( c ) of all samples can be explored through the interactive web browser https://chocolat-g2p.dkfz.de/ . d , Validation of inferred perturbation integration. A GLM model predicts the phenotype expression signals based on the estimated probabilities of perturbation presence using Bayesian modelling . Phenotypes are defined as direct target transcripts associated with perturbations such as shPten– Pten and NICD– Notch1 . Expression data were log(1 p )-transformed. GS, a well-established marker for active WNT signalling in murine livers, was used to infer mtCtnnb1-GS-positive phenotype via IHC on a corresponding serial section. Baseline depicts background phenotype marker expression. Data are presented as feature coefficients shown as mean and error bars depict 3σ confidence intervals (CIs). Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Mapping GS IHC data are derived from three corresponding sections from a single RUBIX experiment with two animals. A representative sample section is displayed.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Staining, Transformation Assay, Expressing, Control, Biomarker Discovery, Marker, Derivative Assay

    a , Quantitative reproducibility. Scatterplots of inferred perturbation probabilities for nodules on the primary section to those on the corresponding replica sections, with Pearson’s correlation values displayed. In total, 136 nodule pairs were analysed. b , Matching nodules across samples. Spatial maps of the inferred probabilities (as in Fig. ) indicating the presence or absence of each of the 8 perturbations associated with annotated tumour nodules for all samples that have matching ROIs from a single RUBIX experiment with two animals. Matching nodules were manually annotated (Methods). Addition of “_Cyt” in sample name indicates use of 10X CytAssist. Number of matching nodules is indicated.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Quantitative reproducibility. Scatterplots of inferred perturbation probabilities for nodules on the primary section to those on the corresponding replica sections, with Pearson’s correlation values displayed. In total, 136 nodule pairs were analysed. b , Matching nodules across samples. Spatial maps of the inferred probabilities (as in Fig. ) indicating the presence or absence of each of the 8 perturbations associated with annotated tumour nodules for all samples that have matching ROIs from a single RUBIX experiment with two animals. Matching nodules were manually annotated (Methods). Addition of “_Cyt” in sample name indicates use of 10X CytAssist. Number of matching nodules is indicated.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques:

    a – c , Perturbation–phenotype association. Spatially resolved visualization of the inferred probabilities indicating the presence or absence of each of the 8 perturbations associated with annotated tumour nodules (Methods). a , A representative sample is displayed. A generalized linear model (GLM) predicts phenotype expression signals based on the estimated probabilities of perturbation presence (Methods). b , Phenotypes are defined as direct target transcripts associated with perturbations such as shKmt2c-Kmt2c and shTrp53-Trp53. Expression data are log1p-transformed. Note that shTrp53 is linked to a GFP peptide barcode and shKmt2c is linked to a RFP barcode (Extended Data Fig. ). c , Hence we infer shTrp53-GFP-positive phenotype and shKmt2c-RFP-positive phenotype. Representative IHCs for a corresponding ROI on a serial section. Baseline depicts background phenotype marker expression. Data are presented as feature coefficients shown as mean and error-bars depict 3σ confidence intervals. As in Fig. , and d . d , H&E and IHC for GFP, RFP, GS. Three representative FFPE samples from a single RUBIX experiment with two animals were sectioned and stained for H&E (see Extended Data Fig. ). GFP and RFP IHC staining was performed on two individual serial sections. GS IHC staining was performed on serial sections. GFP and RFP were embedded in perturbation plasmids as orthogonal barcodes (see Methods and Extended Data Fig. ). GS is a well-known marker for liver WNT/mtCtnnb1-signalling activity (see Fig. ). e , GFP and RFP detection for the same hepatocellular tumour nodules to spatially map peptide barcode combinations associated with introduced perturbations. Left: H&E. Zoom-in: GFP and RFP respectively. Note that one tumour nodule is positive for RFP alone whereas the other tumour nodule is positive for both GFP as well as RFP peptide barcodes. A representative example is shown. Data is derived from 324 nodules across 6 topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Mapping GFP and RFP IHC data is derived from 3 corresponding sections from a single RUBIX experiment with two animals.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a – c , Perturbation–phenotype association. Spatially resolved visualization of the inferred probabilities indicating the presence or absence of each of the 8 perturbations associated with annotated tumour nodules (Methods). a , A representative sample is displayed. A generalized linear model (GLM) predicts phenotype expression signals based on the estimated probabilities of perturbation presence (Methods). b , Phenotypes are defined as direct target transcripts associated with perturbations such as shKmt2c-Kmt2c and shTrp53-Trp53. Expression data are log1p-transformed. Note that shTrp53 is linked to a GFP peptide barcode and shKmt2c is linked to a RFP barcode (Extended Data Fig. ). c , Hence we infer shTrp53-GFP-positive phenotype and shKmt2c-RFP-positive phenotype. Representative IHCs for a corresponding ROI on a serial section. Baseline depicts background phenotype marker expression. Data are presented as feature coefficients shown as mean and error-bars depict 3σ confidence intervals. As in Fig. , and d . d , H&E and IHC for GFP, RFP, GS. Three representative FFPE samples from a single RUBIX experiment with two animals were sectioned and stained for H&E (see Extended Data Fig. ). GFP and RFP IHC staining was performed on two individual serial sections. GS IHC staining was performed on serial sections. GFP and RFP were embedded in perturbation plasmids as orthogonal barcodes (see Methods and Extended Data Fig. ). GS is a well-known marker for liver WNT/mtCtnnb1-signalling activity (see Fig. ). e , GFP and RFP detection for the same hepatocellular tumour nodules to spatially map peptide barcode combinations associated with introduced perturbations. Left: H&E. Zoom-in: GFP and RFP respectively. Note that one tumour nodule is positive for RFP alone whereas the other tumour nodule is positive for both GFP as well as RFP peptide barcodes. A representative example is shown. Data is derived from 324 nodules across 6 topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Mapping GFP and RFP IHC data is derived from 3 corresponding sections from a single RUBIX experiment with two animals.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Expressing, Transformation Assay, Marker, Staining, Immunohistochemistry, Activity Assay, Derivative Assay

    a , Genotype maps (right); 2 8 powerset embedding of spatially mapped perturbations encompassing 324 nodules across six topographically separated regions. Each of the 256 combinations is colour-coded. Perturbation probabilities for a representative nodule are depicted (left; black text highlights present perturbations, while grey text highlights absent perturbations). Nodules sharing representative similar genotypes are encircled and indicated in b (solid lines, Myc + mtCtnnb1 + NICD; dashed lines, Myc + mtCtnnb1 + shKmt2c + NICD + shRen + shTrp53 + shPten). b , Clonal selection. Observed occurrences of genotypically defined tumour clones (median and 95% CI) across 2 8 powerset embedding (top). Grey text indicates combinatorial complexity. The highlighted genotypes are encircled in a . Probability p (O > E) that observed occurrences (O) deviate from the expected baseline distribution (E) ( ; bottom). Deviations of >0.5 indicate increased tumorigenic potential (orange), whereas values of <0.5 suggest potentially disadvantageous combinations (blue). c , Combinatorial order distribution. Observed distribution of the perturbation integration order (mean and 95% CI). A binomial distribution with p = 0.5 is included as a reference of a random unbiased integration rate (red line). d , Ranking of cancer-driving perturbations. Marginal frequencies of individual perturbations in descending order (mean and 95% CI). e , Pairwise co-occurrence and mutual exclusivity patterns. An OR > 1 suggests co-occurrence, whereas OR < 1 indicates mutual exclusivity . Perturbations are ordered according to d . f , Identification of pairwise genetic interactions. Comparison of observed versus expected frequencies (median and 95% CI) for selected gene pairs, calculated using multiplicative models of gene interaction. We simulated the expected probabilities for the pairwise groups under the assumption of no interaction OR, which indicates the direction of the gene interaction effect (arrows), are reported along with the corresponding P values. OR values were estimated from 5,000 posterior samples. A softmax GLM with interaction fixed at one defined the null. P values reflect two-tailed deviations of observed double-positive proportions from the null based on 5,000 draws . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Bayesian modelling of perturbation probabilities was used to infer the occurrence of individual perturbation combinations per nodule. From the inferred Bayesian posterior, we sampled 5,000 points and computed the median and CI for the frequencies of individual perturbations as well as individual genotypes and calculated the OR . H0, null hypothesis.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Genotype maps (right); 2 8 powerset embedding of spatially mapped perturbations encompassing 324 nodules across six topographically separated regions. Each of the 256 combinations is colour-coded. Perturbation probabilities for a representative nodule are depicted (left; black text highlights present perturbations, while grey text highlights absent perturbations). Nodules sharing representative similar genotypes are encircled and indicated in b (solid lines, Myc + mtCtnnb1 + NICD; dashed lines, Myc + mtCtnnb1 + shKmt2c + NICD + shRen + shTrp53 + shPten). b , Clonal selection. Observed occurrences of genotypically defined tumour clones (median and 95% CI) across 2 8 powerset embedding (top). Grey text indicates combinatorial complexity. The highlighted genotypes are encircled in a . Probability p (O > E) that observed occurrences (O) deviate from the expected baseline distribution (E) ( ; bottom). Deviations of >0.5 indicate increased tumorigenic potential (orange), whereas values of <0.5 suggest potentially disadvantageous combinations (blue). c , Combinatorial order distribution. Observed distribution of the perturbation integration order (mean and 95% CI). A binomial distribution with p = 0.5 is included as a reference of a random unbiased integration rate (red line). d , Ranking of cancer-driving perturbations. Marginal frequencies of individual perturbations in descending order (mean and 95% CI). e , Pairwise co-occurrence and mutual exclusivity patterns. An OR > 1 suggests co-occurrence, whereas OR < 1 indicates mutual exclusivity . Perturbations are ordered according to d . f , Identification of pairwise genetic interactions. Comparison of observed versus expected frequencies (median and 95% CI) for selected gene pairs, calculated using multiplicative models of gene interaction. We simulated the expected probabilities for the pairwise groups under the assumption of no interaction OR, which indicates the direction of the gene interaction effect (arrows), are reported along with the corresponding P values. OR values were estimated from 5,000 posterior samples. A softmax GLM with interaction fixed at one defined the null. P values reflect two-tailed deviations of observed double-positive proportions from the null based on 5,000 draws . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Bayesian modelling of perturbation probabilities was used to infer the occurrence of individual perturbation combinations per nodule. From the inferred Bayesian posterior, we sampled 5,000 points and computed the median and CI for the frequencies of individual perturbations as well as individual genotypes and calculated the OR . H0, null hypothesis.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Selection, Clone Assay, Comparison, Two Tailed Test, Derivative Assay

    a , The tumour ecosystem. Spatial maps of tumour-intrinsic phenotypes (top) and TME phenotypes (bottom) across six topographically separated regions. Colour shade depicts aggregated log(1 p )-transformed expression of phenotype-associated transcripts (colour-code as in b and d ). Nodule borders are highlighted (grey). The aggregated values for all samples and underlying quantitative data of individual transcript expression can be explored through the interactive web browser interface ( https://chocolat-g2p.dkfz.de/ ). b , Co-clustering of tumour-intrinsic phenotypes by associated transcripts. Tumour phenotypes are colour-coded. c , Associations between tumour-intrinsic and TME phenotypes. Pearson’s correlation coefficient for each pair of tumour-intrinsic and TME phenotype-associated transcripts across all nodules. d , Co-clustering of TME phenotypes by associated transcripts. TME phenotypes are colour-coded. b , d , Clustering based on Spearman correlations. Phenotypes are subdivided using hierarchical clustering. Scaled ( p 10 ) estimated plasmid probabilities per nodule are indicated ( b (bottom) and d (left) . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , The tumour ecosystem. Spatial maps of tumour-intrinsic phenotypes (top) and TME phenotypes (bottom) across six topographically separated regions. Colour shade depicts aggregated log(1 p )-transformed expression of phenotype-associated transcripts (colour-code as in b and d ). Nodule borders are highlighted (grey). The aggregated values for all samples and underlying quantitative data of individual transcript expression can be explored through the interactive web browser interface ( https://chocolat-g2p.dkfz.de/ ). b , Co-clustering of tumour-intrinsic phenotypes by associated transcripts. Tumour phenotypes are colour-coded. c , Associations between tumour-intrinsic and TME phenotypes. Pearson’s correlation coefficient for each pair of tumour-intrinsic and TME phenotype-associated transcripts across all nodules. d , Co-clustering of TME phenotypes by associated transcripts. TME phenotypes are colour-coded. b , d , Clustering based on Spearman correlations. Phenotypes are subdivided using hierarchical clustering. Scaled ( p 10 ) estimated plasmid probabilities per nodule are indicated ( b (bottom) and d (left) . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Transformation Assay, Expressing, Plasmid Preparation, Derivative Assay

    a , Identification of genotype–phenotype relationships. Comparison of the prevalence of perturbations between phenotypic groups and the remainder of the nodules (total n = 324) for tumour-intrinsic phenotypes (top) and TME (bottom) using ORs. OR > 1 indicates enrichment of perturbations within the phenotypic group; OR < 1 indicates depletion . The number of nodules with a given phenotype ( n ) is indicated. Note that groups are not mutually exclusive. The median and 90% CI are reported. Significant relationships are indicated (exact P values are provided); two-tailed deviations from one, computed with 20,000 samples from the posterior ; *** P < 0.001, ** P < 0.01, * P < 0.05. b , Identification of genotype–phenotype relationships for genes associated with cholangiocytes. A GLM model predicts gene expression signals at each 10X Visium spot using estimated probabilities of perturbation presence . Feature coefficients, shown as the mean and 3σ CIs, indicate associations between gene expression and perturbations for representative transcripts. Bayesian modelling of perturbation probabilities was used to infer the occurrence of individual perturbations per nodule . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Identification of genotype–phenotype relationships. Comparison of the prevalence of perturbations between phenotypic groups and the remainder of the nodules (total n = 324) for tumour-intrinsic phenotypes (top) and TME (bottom) using ORs. OR > 1 indicates enrichment of perturbations within the phenotypic group; OR < 1 indicates depletion . The number of nodules with a given phenotype ( n ) is indicated. Note that groups are not mutually exclusive. The median and 90% CI are reported. Significant relationships are indicated (exact P values are provided); two-tailed deviations from one, computed with 20,000 samples from the posterior ; *** P < 0.001, ** P < 0.01, * P < 0.05. b , Identification of genotype–phenotype relationships for genes associated with cholangiocytes. A GLM model predicts gene expression signals at each 10X Visium spot using estimated probabilities of perturbation presence . Feature coefficients, shown as the mean and 3σ CIs, indicate associations between gene expression and perturbations for representative transcripts. Bayesian modelling of perturbation probabilities was used to infer the occurrence of individual perturbations per nodule . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Comparison, Two Tailed Test, Gene Expression, Derivative Assay

    a , Tumour-intrinsic genotype–phenotype relations. A generalized linear model (GLM) predicts gene expression signals at each 10X Visium spot, using estimated probabilities of perturbation presence (Methods). Data are presented as feature coefficients shown as mean and error bars depict 3σ confidence intervals. Feature coefficients indicate associations between gene expression and perturbations for representative transcripts of four tumour-intrinsic phenotypes. b , TME-related genotype–phenotype relations. As in a for representative transcripts of two exemplary TME phenotypes. c , GLM-inferred genotype–phenotype associations. Top: heatmap of 1,283 genes with at least one significant (3σ) feature weight, ordered by 1D UMAP embedding. Bottom: Detailed views of four representative clusters linked to marker genes of known phenotypic groups. Data is derived from 324 nodules across 6 topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Tumour-intrinsic genotype–phenotype relations. A generalized linear model (GLM) predicts gene expression signals at each 10X Visium spot, using estimated probabilities of perturbation presence (Methods). Data are presented as feature coefficients shown as mean and error bars depict 3σ confidence intervals. Feature coefficients indicate associations between gene expression and perturbations for representative transcripts of four tumour-intrinsic phenotypes. b , TME-related genotype–phenotype relations. As in a for representative transcripts of two exemplary TME phenotypes. c , GLM-inferred genotype–phenotype associations. Top: heatmap of 1,283 genes with at least one significant (3σ) feature weight, ordered by 1D UMAP embedding. Bottom: Detailed views of four representative clusters linked to marker genes of known phenotypic groups. Data is derived from 324 nodules across 6 topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Gene Expression, Marker, Derivative Assay

    a , Spatially resolved co-occurence of VEGFA and mutual exclusivity of mtCtnnb1 for the CCA tumour subtype as revealed by C-G2P. Magnified views of three representative nodules ((i)–(iii)) identified as CCA. Nodules identified as CCA (left; the area covered by the tumour nodule is indicated as 10X Visium spots in yellow) as well as the mtCtnnb1 (middle; as in Fig. ) and VEGFA (as in Fig. ) perturbation probabilities are shown. Bayesian modelling of perturbation probabilities is used to infer the occurrence of individual perturbations per nodule . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Perturbation probabilities for all samples can be explored through the interactive web browser https://chocolat-g2p.dkfz.de/ . b , Experimental design. Parallel RUBIX mouse models were performed using the leave-one-out experimental design. c , Time to tumour occurrence. Animals were palpated twice weekly to monitor tumour development. d , Histological quantification of liver tumour subtypes. H&E images were analysed, and tumour nodules were counted and classified as either HCC (top) or CCA (bottom); two independent liver-tissue sections per animal. The median ± s.d. alongside individual tumour counts are indicated. Group comparisons used a two-sided Kruskal–Wallis test with Dunn’s post-hoc test (Holm–Bonferroni correction). Exact adjusted P values are shown. e , Abundance of CCA. CK19 IHC was used as a cholangiocyte marker. Representative samples from a total of two separate sections per animal are depicted. b – e , n = 4 animals per group.

    Journal: Nature Biomedical Engineering

    Article Title: Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships

    doi: 10.1038/s41551-025-01437-1

    Figure Lengend Snippet: a , Spatially resolved co-occurence of VEGFA and mutual exclusivity of mtCtnnb1 for the CCA tumour subtype as revealed by C-G2P. Magnified views of three representative nodules ((i)–(iii)) identified as CCA. Nodules identified as CCA (left; the area covered by the tumour nodule is indicated as 10X Visium spots in yellow) as well as the mtCtnnb1 (middle; as in Fig. ) and VEGFA (as in Fig. ) perturbation probabilities are shown. Bayesian modelling of perturbation probabilities is used to infer the occurrence of individual perturbations per nodule . Data are derived from 324 nodules across six topographically separated regions used for 10X Visium from a single RUBIX experiment with two animals. Perturbation probabilities for all samples can be explored through the interactive web browser https://chocolat-g2p.dkfz.de/ . b , Experimental design. Parallel RUBIX mouse models were performed using the leave-one-out experimental design. c , Time to tumour occurrence. Animals were palpated twice weekly to monitor tumour development. d , Histological quantification of liver tumour subtypes. H&E images were analysed, and tumour nodules were counted and classified as either HCC (top) or CCA (bottom); two independent liver-tissue sections per animal. The median ± s.d. alongside individual tumour counts are indicated. Group comparisons used a two-sided Kruskal–Wallis test with Dunn’s post-hoc test (Holm–Bonferroni correction). Exact adjusted P values are shown. e , Abundance of CCA. CK19 IHC was used as a cholangiocyte marker. Representative samples from a total of two separate sections per animal are depicted. b – e , n = 4 animals per group.

    Article Snippet: The endogenous transcripts associated with the REDPRO-BCs used in this study are illustrated in Extended Data Fig. and the respective nucleotide sequences for 10X Visium RTL-probe capture barcodes (reverse complement to RTL-probe sequence provided by 10X Genomics) are listed under the section ‘Molecular cloning’.

    Techniques: Derivative Assay, Marker